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Abstract
Introduction: One of the ensuing complications of placenta accreta includes loss of fertility.
Case presentation: An Asian origin Indian national patient with history of placenta accreta at the
time of previous delivery and had conservative management with injection methotrexate after the
failure of surgical intervention, conceives again and has uneventful antenatal period and parturition.
Conclusion: Conservative strategy of leaving the excessively adherent placenta in-situ alongwith
adjuvant therapy in the form of injection methotrexate, not only prevents dreadful complications
but also retains fertility in haemodynamically stable patients desirous of future pregnancy.
Introduction
One of the potentially catastrophic obstetric complications,
Placenta accreta is alarmingly on the rise, with high mater-
nal morbidity and mortality rate being as high as 7% [1]. It
is considered as an anomaly in placentation leading to its
abnormally firm attachment to the myometrium due to the
absence of decidua basalis leading to its incomplete separa-
tion at the time of delivery. The untoward complications
may include- severe post-partum haemorrhage with its
resultant coagulopathy, uterine perforation, shock, infec-
tion, loss of fertility and even death [2].
Case presentation
A patient aged 33 years of Asian origin Indian national
(with Hindu religion), reported missing her menstruation
by 10 days and tested positive for pregnancy. Her obstetric
history read third gravida with parity two, but one living
child. The last time she was pregnant she had retained pla-
centa following full-term vaginal delivery at home, com-
plicated by post-partum haemorrhage.
Thereafter, being taken to a private hospital, she under-
went three unsuccessful attempts of manual removal and
uterine curettage and five units of blood transfusion inter-
spersed with repeated episodes of excessive bleeding per
vaginally. Failing to be managed by this surgical
approach, she was referred for hysterectomy. Her first ges-
tation period and vaginal delivery were uneventful.
On admission at Maharishi Markendeshwar Institute of
Medical Sciences and Research (MMIMSR) after 18 days of
parturition, she was conscious, cooperative, moderately
built with body weight-50 kg, having stable general con-
dition and normal vitals but with significant pallor, no
cyanosis and nothing abnormal detected on respiratory or
cardio-vascular system examination. On abdominal
examination- uterus was felt enlarged to 20 weeks size,
well contracted with Pelvic examination showing moder-
ate amount of bleeding per vaginum and patulous but
closed os of 20-22 wks sized uterus.
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Investigations revealed her Haemoglobin to be 7.5 gm%,
blood group B positive; rest of the haemogram, urine rou-
tine examination, platelet count, coagulation profile, liver
function and renal function tests were normal. Vaginal
swab was sent for culture and sensitivity which later
reported sterile. Sonography of abdomen revealed uterus
to be enlarged with endometrial cavity showing an echo-
genic mass of dimensions 8.1 cm × 5.8 cm attached pos-
teriorly, suggestive of placenta, with Colour Doppler
confirming it to be posterior, low lying placenta accreta
with no definite myometrial invasion (Figure 1).
Supportive measures, like one unit blood transfusion and
broad-spectrum antibiotics, initiated. Considering the
haemodynamically stable condition and minimal vaginal
bleeding, she was managed conservatively. Modality
adopted: placenta left insitu and injection methotrexate
given intramuscularly in the dosage of 1 mg/kg body
weight (i.e. single dose of 50 mg) repeated at 72-96 hourly
intervals for a total three doses depending upon the
dimension and vascularity of the endometrial mass repre-
senting adherent placenta with serial Ultrasonography
and colour Doppler studies which showed gradual reduc-
tion. Total and Differential Leucocyte counts were rou-
tinely done and remained within normal limits. Size of
the uterus decreased remarkably and was not palpable
per-abdomen after 7 days. Vaginally, bleeding never
became alarming and the discharge never appeared
infected.
Patient was discharged satisfactorily after 11 days. On sub-
sequent three follow-up visits, every 5 days, patient
remained afebrile with no evidence of infection, and near
normal ultrasonographic findings after a fornight. Patient
started menstruating regularly after about four months.
Present pregnancy happened after 8 months of the above
mentioned previous eventful post-natal period. In her reg-
ular antenatal visits, Ultrasonography and colour Doppler
were conducted at frequent intervals to rule out any evi-
dence of recurrent Placenta accreta. At term, she had cae-
sarean section for foetal indication. The placental
separation was normal and post natal period uneventful
Discussion
The ever increasing incidence of life endangering condi-
tion of placenta accreta is considered between 1 in 7000
to as high as 1 in 540 pregnancies [3]. The risk factors for
placenta accreta are -previous uterine surgery(like caesar-
ean sections, Myomectomy), previous dilation & evacua-
tion, placenta praevia, advanced maternal age,
multiparity, Asherman's Syndrome and presence of sub-
mucous leiomyomata [4,5]. It is important to make an
early and accurate diagnosis by Ultrasound, Colour Dop-
pler, MRI for appropriate management and reduction of
associated morbidity, thereof [6].
Two strategies for the management of placenta accreta
have been described: surgical removal of the uterus and
conservative management. Presently, there has been a
gradual shift towards its conservative management pio-
neered by Arulkumaran et al [7], away from the age old
traditional approach of hysterectomy. The current trend is
of uterine conservation and leaving the adherent placenta
in-situ with adjuvant treatment with Methotrexate [8].
Mussali et al [9], in 2000, managed three cases of placenta
accreta with methotrexate and succeded in preserving the
uterus in two cases. One case of placenta percreta and
three cases of partial placenta increta were managed effec-
tively with methotrexate by Sonin in 2001 [10], and
Pinho et al in 2008 [11], respectively.
Another study on conservative management mentions
leaving the placenta accreta in situ with one of these asso-
ciated treatments like -bilateral hypogastric artery ligation,
medical treatment with Methotrexate or uterine artery
embolisation,: placental resorption happened in majority
of the cases with no report of maternal mortality but two
cases failed where hysterectomy was performed -in one
case for life threatening haemorrhage and in the other for
post-embolisation uterine necrosis [12].
Though uterine artery embolisation may be regarded as an
alternative to surgery for control of obstetric haemorrhage
in placenta accreta [13], its safety for women desiring
future pregnancy is controversial [14].
According to Heiskanen et al [15], conservative manage-
ment of adherent placenta with methotrexate to preserve
future fertility remains a secure and reasonable alternative
in haemodynamically stable patients when there is no
active bleeding.
Abnormally adherent placenta Figure 1
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Conclusion
Conservative strategy of leaving adherent placenta in-situ
with adjuvant methotrexate deserves consideration in
selected patients of placenta accreta who are haemody-
namically stable and with no active bleeding, especially in
those category where retention of fertility is required.
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